StockData
Capricor Therapeutics, Inc. logo

Capricor Therapeutics, Inc. (CAPR) stock

CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$8.41+0.11 (+1.33%)

Close on Nov 17, 2026Market cap $488.95MP/E –Yield –

Capricor Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Capricor Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$104.00M. For fiscal 2025 it was -$69.81M. The highest annual figure on record is $4.92M in fiscal 2022.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$69.81M–
FY2024Dec 31, 2024-$40.00M–
FY2023Dec 31, 2023-$25.60M-620.6%
FY2022Dec 31, 2022$4.92M–
FY2021Dec 31, 2021-$16.81M–
FY2020Dec 31, 2020-$10.05M–
FY2019Dec 31, 2019-$6.82M–
FY2018Dec 31, 2018-$13.86M–
FY2017Dec 31, 2017-$14.23M–
FY2016Dec 31, 2016-$14.45M–
FY2015Dec 31, 2015-$10.82M-1228.5%
FY2014Dec 31, 2014$958.56K–
FY2013Dec 31, 2013-$6.14M–
FY2012Dec 31, 2012-$2.06M–
FY2011Dec 31, 2011-$4.65M–
FY2010Dec 31, 2010-$4.32M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$31.49M–
Q1 FY2026Mar 31, 2026-$29.25M–
Q4 FY2025Dec 31, 2025-$23.57M–
Q3 FY2025Sep 30, 2025-$19.69M–
Q2 FY2025Jun 30, 2025-$20.12M–
Q1 FY2025Mar 31, 2025-$6.43M–
Q4 FY2024Dec 31, 2024-$14.80M–
Q3 FY2024Sep 30, 2024-$11.64M–
Q2 FY2024Jun 30, 2024-$12.29M–
Q1 FY2024Mar 31, 2024-$1.27M-130.1%
Q4 FY2023Dec 31, 2023-$11.59M–
Q3 FY2023Sep 30, 2023-$8.79M–
Q2 FY2023Jun 30, 2023-$9.42M–
Q1 FY2023Mar 31, 2023$4.21M-82.5%
Q4 FY2022Dec 31, 2022-$6.90M–
Q3 FY2022Sep 30, 2022-$5.69M–
Q2 FY2022Jun 30, 2022-$6.54M–
Q1 FY2022Mar 31, 2022$24.05M–
Q4 FY2021Dec 31, 2021-$5.63M–
Q3 FY2021Sep 30, 2021-$3.34M–
Q2 FY2021Jun 30, 2021-$4.51M–
Q1 FY2021Mar 31, 2021-$3.33M–
Q4 FY2020Dec 31, 2020-$3.84M–
Q3 FY2020Sep 30, 2020-$2.98M–
Q2 FY2020Jun 30, 2020-$2.02M–
Q1 FY2020Mar 31, 2020-$1.22M–
Q4 FY2019Dec 31, 2019-$1.79M–
Q3 FY2019Sep 30, 2019-$1.65M–
Q2 FY2019Jun 30, 2019-$1.78M–
Q1 FY2019Mar 31, 2019-$1.61M–
Q4 FY2018Dec 31, 2018-$3.77M–
Q3 FY2018Sep 30, 2018-$2.98M–
Q2 FY2018Jun 30, 2018-$3.69M–
Q1 FY2018Mar 31, 2018-$3.42M–
Q4 FY2017Dec 31, 2017-$2.67M–
Q3 FY2017Sep 30, 2017-$3.19M–
Q2 FY2017Jun 30, 2017-$3.70M–
Q1 FY2017Mar 31, 2017-$4.68M–
Q4 FY2016Dec 31, 2016-$3.48M–
Q3 FY2016Sep 30, 2016-$1.91M–

More Capricor Therapeutics figures

See a number that looks wrong?